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Abstract 
The association between depressive symptoms and elevated cortisol levels, and depression and 
cognitive functioning, has been less robust in outpatients with symptoms in the mild to moderate 
range. Furthermore, the association between elevated cortisol levels and cognitive functioning is 
unclear. In the present study, currently depressed (n = 37), previously depressed (n = 81) and never 
depressed controls (n = 50) were assessed on a range of neuropsychological measures. Salivary 
cortisol was measured in the morning and evening. Participants with current depression were non-
hospitalized and had symptoms predominately in the mild to moderate range. Elevated salivary 
evening cortisol, but not morning cortisol, was significantly related to depressive symptoms. The 
difference in cortisol levels between the previously depressed group and the never depressed controls 
was not significant. The groups had significantly different cognitive profiles, with the currently 
depressed performing poorer on tasks related to working memory compared to the never depressed 
controls. Both the currently and previously depressed performed worse on attentional tasks. The 
findings indicate that outpatients with mild to moderate depression have elevated cortisol levels and 
limited mild cognitive impairments. Furthermore, mild impairments in attention may persist after 
remission, indicating that this could be a trait-marker in depression. The present study did not find 
support for a significant relationship between cortisol and cognitive functioning. 
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1. Introduction 
Major depression is a prevalent and impairing disorder (Wittchen and Jacobi, 2005). In 
addition to disturbances in mood, motivation and vegetative functioning, there is solid evidence 
indicating that depression is associated with cognitive impairments in its acute phase (Hammar and 
Årdal, 2009; Rock et al., 2014). Deficits are most common in the domains of memory (Hinkelmann et 
al., 2013), executive functioning (Snyder, 2013), attention (Rock et al., 2014), and psychomotor speed 
(Egeland et al., 2005). However, it has been difficult to establish a cognitive profile characterizing 
depressed patients, and findings are diverse, with some studies failing to find substantial cognitive 
deficits in depressed individuals (Halvorsen et al., 2012; Krogh et al., 2012). The diversity of results is 
possibly related to the heterogeneity of depression, and hence, the differences between studied patient 
groups, for instance with regard to severity, subtype, and the presence of psychotic symptoms and 
comorbid disorders (Hammar and Årdal, 2009).   
Stressful life events, including past or recent traumatic experiences, are associated with an 
increased risk for developing a depressive episode (e.g., Tennant, 2002). In addition, depression is in 
itself a stressful event. Thus, several studies have investigated the functioning of the hypothalamic-
pituitary-adrenal (HPA) axis in individuals suffering from depression. Upon stress exposure, the HPA-
axis becomes activated. This triggers the release of corticotropin-releasing hormone (CRH) from the 
hypothalamus which stimulates the secretion of adrenocorticotropin (ACTH) from the pituitary gland, 
which in turn triggers the release of glucocorticoids (cortisol) from the adrenal cortex (Lupien et al., 
2007). Under normal conditions, glucocorticoids follow a 24-hour circadian rhythm with peaking 
concentrations in the morning and a gradual decline during late afternoon, evening and night (Lupien 
et al., 2007). Free cortisol is commonly measured in saliva. Salivary cortisol levels generally correlate 
well with free unbound cortisol in blood (Hellhammer et al., 2009). Hypersecretion of cortisol in 
depression is supported by several studies (Hinkelmann et al., 2013; Vreeburg et al., 2009), but not all 
(Krogh et al., 2012; Michopoulos et al., 2008). Meta-analyses conclude that cortisol levels are 
significantly increased in depressed patients compared to controls both in the morning and evening 
(Knorr et al., 2010; Stetler and Miller, 2011). However, the degree of HPA-hyperactivity varies 
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substantially and is more pronounced in patients who are hospitalized and whose depression has 
psychotic, melancholic or endogenous features (Stetler and Miller, 2011).  
There is growing evidence that cognitive impairment in depression may persist in a remitted 
state (e.g., Hasselbalch et al., 2011; Reppermund et al., 2008). Yet others suggest that such 
impairments may be reversible upon recovery (Biringer et al., 2005). With regard to HPA-axis 
dysregulation, some research indicates that this is state-dependent and normalizing with successful 
symptom relief (Hinkelmann et al., 2012; Reppermund et al., 2007). However, several studies show 
that dysregulation may persist despite recovery (McKay and Zakzanis, 2010; Vreeburg et al., 2009), 
and may predict recurrence of the disorder (Zobel et al., 2001). This, together with studies showing 
abnormal HPA-axis functioning in young non-depressed individuals at familial risk (Mannie et al., 
2007), poses the question that such abnormalities may represent a trait-marker of depression. 
Cortisol binds to two subtypes of receptors throughout the brain, both which are prominent in 
the hippocampus and prefrontal cortex which are brain areas related to memory and executive 
functioning (Lupien et al., 2007). The mineralocorticoid receptor (MR) has high affinity for cortisol, 
and MRs are therefore almost entirely occupied under conditions with basal levels of glucocorticoid 
secretion (Anacker et al., 2011). The other receptor, the glucocorticoid receptor (GR) has low affinity 
for cortisol. Thus, under normal conditions, this receptor is more moderately occupied. It becomes 
fully activated at higher concentrations, such as under stress or at the peak of the circadian rhythm of 
cortisol secretion (Holsboer, 2000). Due to its activation at higher concentrations, the GR appears to 
have a crucial role in regulating glucocorticoid levels under stressful circumstances through negative 
feedback on the HPA-axis inhibiting production and secretion of CRH and ACTH (Juruena et al., 
2004). Furthermore, abnormal GR functioning at the limbic-hippocampal level (GR resistance) 
resulting in impaired negative feedback inhibition and increased release of CRH, is proposed as a 
mechanism for the overactivity of the HPA-axis in depression and as being involved in causing 
depression. 
Prolonged excessive exposure to cortisol due to Cushing’s syndrome (Forget et al., 2002) and 
long-term corticosteroid treatment (Brown et al., 2004) is associated with cognitive impairments; 
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results suggestive of a neurotoxic effect. The association between HPA-axis activity and cognitive 
performance in depressed individuals remains unclear. Some studies suggest that there is indeed an 
association (e.g., Egeland et al., 2005; Gomez et al., 2006; Keller et al., 2016). However, others fail to 
document a relationship (Krogh et al., 2012; Michopoulos et al., 2008; Vythilingam et al., 2004). 
Similarly, it has been difficult to confirm the neurotoxicity of cortisol in depression by establishing a 
direct relationship between the peripheral glucocorticoid system and decreased hippocampal volume, 
which could further affect cognitive functions (Colla et al., 2007; Kaymak et al., 2010). However, a 
recent pilot study indicated that the link between cortisol and hippocampal volume may be more 
complex and rely on the interaction between cortisol and other steroid hormones (Jin et al., 2016). The 
fact that depression tends to recur for 50 - 80 % of patients, thus inflicting prolonged cortisol 
hypersecretion, also raises the question as to whether there are different cognitive profiles for patients 
with single-episode and recurrent depression, as suggested by some studies (Hasselbalch et al., 2013).  
1.2. Aims 
The aim of this study was fourfold. 1. The association between elevated HPA-axis activity and 
depressive symptoms in outpatients with symptoms in the mild to moderate range has been less robust 
in previous studies (Krogh et al., 2012; Stetler and Miller, 2011). Therefore, we firstly aimed to study 
the relationship between salivary cortisol and depressive symptoms in a sample including non-
hospitalized mildly to moderately depressed individuals, previously depressed individuals currently in 
a remitted state, and never depressed healthy controls. Based on previous studies we hypothesised that 
depressive symptoms will be positively correlated with cortisol levels. 2. Further, we studied group 
differences in cortisol level, focusing on both potential differences between the currently depressed 
and never depressed groups, and whether the previously depressed group differed from the other 
groups. In addition, possible differences in cortisol between individuals having experienced single 
versus recurrent depression was studied. As earlier research has proposed HPA-axis dysregulation as a 
trait marker in depression, our hypothesis is that cortisol levels will be elevated both in the currently 
and previously depressed group. 3. The third aim was to investigate whether there were different 
cognitive profiles for the groups of currently, previously and never depressed, when assessed on a 
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range of neuropsychological measures. The neuropsychological data from the sample has previously 
been analysed for differences using single tests as the main outcome (Halvorsen et al., 2012). The 
present article builds on this by investigating difference in cognitive profiles using components based 
on factor analysis as the outcome. Due to the relatively mild severity of the sample, we hypothesised 
that the currently depressed group would show mild and limited impairments on neuropsychological 
tests, and that this would be evident in the previously depressed group as well. 4. Lastly, exploratory 





The study included 168 participants comprising currently depressed (CD; n = 37), recovered 
previously depressed (PD; n = 81) and individuals who had never experienced depression (ND; n = 
50). Participants were diagnosed in accordance with the Diagnostic and Statistical Manual of Mental 
Disorders, Fourth Edition, Text Revision (DSM-IV-TR; American Psychiatric Association (APA), 
2000) using the Structured Clinical Interview for DSM-IV (SCID; First et al., 1997). Exclusion criteria 
were depression in partial remission as defined in DSM-IV-TR (APA, 2000), dysthymic disorder, 
current or past manic/hypomanic episode or psychotic symptoms, a history of known brain damage 
and major depression due to a general medical condition. Based on information from the clinical 
interview participants were grouped as currently depressed, previously depressed, but in recovery for a 
minimum of 8 weeks, or never depressed without ongoing or past axis-I disorders. Hearing and vision 
was normal or corrected to normal in all participants.  
 Of the 168 participants, 103 were recruited from a previous study of depression and cognitive 
vulnerability among mildly to moderately depressed outpatient younger adults (CD, n = 15; PD, n = 
62; ND, n = 26;  Wang et al., 2005). The remaining 65 participants were recruited from general 
practitioners and through advertisements in a local newspaper. The study was approved by the 
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Regional Committee for Research Ethics, and written informed consent was obtained from all 
participants. For further information regarding the sample and study design see Halvorsen et al. (2012; 
2011). 
2.2. Procedure 
Participants were tested over two consecutive days. The clinical interview, the Beck 
Depression Inventory-II (BDI-II) and neuropsychological testing were conducted during day one, 
whereas salivary cortisol was measured between the two days of testing. Clinical psychologists or 
postgraduate psychology students thoroughly trained by a highly qualified supervisor, performed 
clinical interviews and neuropsychological testing. The clinical interviews were digitally recorded and 
30 interviews (10 from each group) were randomly selected for reliability testing. Interrater agreement 
(kappa) was high both for deciding group allocation (currently, previously or never depressed; k = 0.9) 
and for distinguishing between participants who had or had not been depressed (currently or 
previously depressed versus never depressed; k = 1.0; Halvorsen et al., 2012). Interrater reliability was 
not assessed for comorbid diagnoses. Therefore, exact numbers for comorbid diagnosis are not 
reported. The test session lasted 2 – 3 hours including regular breaks. Tests were presented in the same 
order for all participants. Participants received 150 NOK (~$18) per hour of participation as 
compensation.  
2.3. Cortisol level 
Salivary evening and morning cortisol were sampled by having participants chew on a cotton 
swab (cat.no. 51.1534.500, Salivette®, Sarstedt, Nümbrecht, Germany). Swabs were placed in plastic 
tubes (Salivette®), centrifuged at 1000 x g for 10 minutes and kept frozen (-20©) until analysis. 
Participants were instructed to abstain from eating, drinking and brushing their teeth for at least one 
hour before the evening sample, and to take the morning sample directly after getting up, before 
eating, drinking or brushing their teeth.  
Cortisol was analyzed with an electrochemiluminescence immunoassay (ECLIA) using an 
automated clinical chemistry analyser (Modular P, Roche Diagnostics, Mannheim, Germany). The 
Høifødt, R.S.            Cortisol and cognitive profile in depression                                                               8 
 
lower detection limit was 0.5 nmol/L, and the inter-assay coefficient of variation (CV) in saliva 
samples was 2.7 % at a concentration of 11.5 nmol/L, likewise intra-assay CV was 11.5 %. In serum, 
the within-subject biologic CV is 15.2 %, whereas the between-subject biologic CV is 38.1 % 
according to the Westgard Quality Control database. Similar variation should be reflected in the saliva 
that contains the free fraction of the hormone, i.e. the fraction not bound to transcortin and albumin, 
which is approximately 1/50 of that in serum. The laboratory had a reference interval for morning and 
evening hours of 6 – 29 and 2 – 15 nmol/L, respectively.  
2.4. Instruments 
The BDI-II is a 21-item self-report measure of severity of depressive symptoms during the last 
two weeks (Beck et al., 1996). Each item is rated on a 4-point scale ranging from 0 – 3. The validated 
Norwegian translation was used in the study (Kjærgaard et al., 2014). Studies support the BDI-II as a 
reliable, internally consistent and valid scale for assessing depression (e.g., Beck et al., 1996). 
Beck Anxiety Inventory (BAI) is a 21-item measure of anxiety symptom severity during the 
last week (Beck and Steer, 1993). Each item is rated from 0 to 3. The inventory has shown high 
internal consistency and reliability, as well as robust convergent and discriminant validity (Fydrich et 
al., 1992; Steer et al., 1993). 
2.5. Neuropsychological tests 
All participants were assessed on executive functioning, memory, attention, psychomotor 
speed, and information processing; cognitive domains previously found to be sensitive to dysfunction 
in unipolar depression (Hammar and Årdal, 2009; Rock et al., 2014). Executive functioning was 
assessed using the Delis Kaplan Executive Function System (D-KEFS; Delis et al., 2001); Colour-
Word Interference Test (the variables inhibition and inhibition/switching), D-KEFS Verbal Fluency 
(including the variable category switching; Delis et al., 2001), Wisconsin Card Sorting Test (WCST; 
Heaton, 1993), and Trail Making Test B (Reitan and Wolfson, 1993). Working memory was tested 
using the Digit Span Backward from the Wechsler Adult Intelligence Scale (WAIS-III; Wechsler, 
2003). Tests of psychomotor speed and information processing included the California Computerized 
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Assessment Package RT (CalCap; Miller, 1993), Digit Symbol Coding from WAIS-III (Wechsler, 
2003), Colour-Word Interference Test (the variables color naming and word reading; Delis et al., 
2001), and Trail Making Test A (Reitan and Wolfson, 1993). Attention was assessed with the Digit 
Span Forward from WAIS-III (Wechsler, 2003) and the Seashore Rhythm Test from the Halstead-
Reitan test battery (Reitan and Wolfson, 1993). Verbal learning and memory was evaluated using the 
California Verbal Learning Test, second edition (CVLT-II; Delis et al., 2004). Verbal Fluency was 
tested with the D-KEFS Verbal Fluency subtests (Delis et al., 2001). In addition, the Picture 
Completion and Comprehension subtests from the WAIS-III (Wechsler, 2003) were administered as 
measures of intellectual abilities.  
2.6. Statistical analysis 
Of the 168 participants in the study, 36 missed the morning cortisol measure and 43 missed 
the evening measure. Further, four outliers (two morning, two evening) were excluded due to extreme 
cortisol values (>3 SD above sample mean). For the analyses this leaves a sample of 130 (CD: n = 31; 
PD: n = 61; ND: n = 38) and 123 participants (CD: n = 27; PD: n = 60; ND: n = 36) with a morning 
and evening cortisol measure, respectively. Morning samples were collected between 6 and 10.30 am 
(M = 7.65, SD = 0.78; 91 % collected between 7 am and 9 am), and evening samples were collected 
between 8 pm and 1.30 am (M = 22.47, SD = 0.80; 89 % collected between 9.30 pm and 11.30 pm). 
One evening sample was collected at 6.30 pm. For means, time points after midnight were recoded as 
24 (midnight) and 25 (1 am) to avoid that these time points would have an undue influence on the 
means. There was no significant difference between groups on time of measurement, Fmorning (2,131) = 
2.09, p = .13, ηp2 = 0.03; Fevening (2,123) = 1.26, p = .29, ηp2 = 0.02. As time of measurement did not 
differ between groups and did not correlate significantly with cortisol levels or any of the 
neuropsychological indexes (see description below), this variable was not controlled for in the 
analyses.  
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All analyses were carried out using IBM SPSS Statistics version 24 for Windows (IBM Corp., 
Released 2016). Effect sizes were calculated using the spreadsheet provided by Lakens (2013). 
Differences between groups on demographic and clinical variables were analysed using One-way 
ANOVAs for continuous variables and for categorical variables Chi square test or Fisher’s Exact test 
when appropriate. The associations between depression and cortisol were analysed using non-
parametric tests due to the non-normal distribution of the cortisol-data. We used Spearman’s rho 
correlations with one-tailed significance tests for testing the relationship between depressive 
symptoms (BDI-II) and cortisol, and independent samples Kruskal-Wallis tests for analysing group 
differences. An independent-samples Jonckheere-Terpstra test was carried out to determine if there 
was a significant ordered trend in medians between the three groups. This was based on the hypothesis 
that there may be an ordering of median cortisol levels from lowest in the healthy control group and 
highest in the currently depressed group. This pattern of results, albeit non-significant, was found in 
the present sample for mean scores on neuropsychological tests (Halvorsen et al., 2012). 
Power analyses were performed with G*Power 3.1.9.2 (Faul et al., 2007). With an alpha level 
of 0.05 the study had a statistical power of 0.88 for detecting small correlations (r = 0.25) between 
BDI-II and cortisol (n = 123 for evening cortisol), and a power of 0.82 for detecting effects of 
moderate size (f2 = 0.15) in a multiple regression analysis with 8 predictors. Originally, the study was 
powered to detect group-differences of moderate effect sizes (d = 0.5, power = 0.80, n = 168), but due 
to missing cortisol data the achieved power for group-differences in cortisol was less than adequate 
(power ~0.70). Nevertheless, results are useful for meta-analytic purposes as all effect sizes are 
reported.  
 Further, we performed a principal components analysis (PCA) for the neuropsychological test 
items (22 variables). Oblique oblimin rotation was chosen because we assumed a certain degree of 
dependency between the underlying factors. We used 1.0 as prior communality estimates. Variables 
with communalities below 0.5 were excluded in order to ensure that the factor solution would account 
for a substantial proportion of variance of included variables. One variable (Simple Reaction Time 
from CalCap) was excluded on this basis. The final analysis including 21 variables retained 6 
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components with eigenvalues above the Kaiser’s criterion of 1. Factor solutions based on the scree 
plot (5 to 6 factors) and parallel analyses were also considered (3 factors). However, the 6 factor 
solution provided the most theoretically sound alternative. The Kaiser-Meyer-Olkin measure indicated 
good sampling adequacy, KMO = .86, and a significant Bartlett’s test of sphericity (p<.001) suggested 
sufficient correlations between variables. Mean index-scores for each of the 6 dimensions were 
calculated using z-transformed variable scores. Only variables with strong factor loadings (≥0.50) 
were included for the index-scores. No variables had strong loadings on more than one factor. The 
correlations between the index-scores and the factor scores from the analysis ranged from .97 to 1.00, 
indicating minimal loss of information.  
Mean index-scores were subsequently used as dependent variables in repeated-measures 
MANOVAs investigating differences in cognitive profiles between the groups of CD, PD and ND. 
Group was included as the between-subjects variable and mean-scores on the 6 cognitive indexes as 
the within-subjects variable. An interaction-effect between group and cognitive index would indicate 
significant different profiles. Index-scores did generally not deviate substantially from normality based 
on histograms and measures of skewness and kurtosis. Further, a non-significant Box-test suggested 
that the assumption of homogeneity of variance-covariance matrices was met. The omnibus 
MANOVA was followed-up by individual ANOVAs for each index. Lastly, the mean index scores 
were used as independent variables in hierarchical regression analyses. Cortisol measures were entered 
as independent variables controlling for demographic variables (gender, age and education), 
medication use, and BDI-II and BAI scores. Bootstrapping (2000 samples) was used to generate 
confidence intervals (percentile) and p-values that do not rely on the assumptions of normality of 
residuals or homoscedasticity. 
 
3. Results 
3.1. Sample characteristics 
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The total sample included 37 currently depressed individuals, 81 previously depressed 
individuals and 50 never depressed controls. Demographic and clinical information for the three 
groups are shown in Table 1. There were no significant differences between the groups on any 
demographic variables, including age, gender, education, intellectual abilities and handedness. On the 
BDI-II there were significant differences between all groups in the expected direction (ND < PD < 
CD; F(2,165) = 133.42, p = <. 001, ηp2 = 0.62). The mean BDI-II score in the PD and ND groups were 
well below the clinical threshold of 14 as defined by Beck, Steer and Brown (see Table 1;  1996), but 
13 individuals in the PD-group had BDI-II score above 13. The depressive severity in the CD-group 
ranged from mild to severe (BDI-II score 12 - 45), with a mean score of moderate severity (see Table 
1). There was also a significant difference between the groups on the BAI, F (2,164) = 58.75, p < .001, 
ηp2 = 0.42 (see Table 1), with post hoc analyses finding significant differences between all groups, ND 
< PD, p = .002, ND < CD, p < .001, PD < CD, p < .001. The mean BAI-scores were minimal in the 
ND and PD groups and within the mild to moderate range in the CD-group (Beck and Steer, 1993). 
The majority of participants in the CD and PD groups had recurrent depression. There was no 
significant difference on BDI-II, F(1,116) = 1.74, p = .19, ηp2 = 0.01, between participants with single 
(M = 11.17, SD = 12.08) versus recurrent depression (M = 14.10, SD = 10.65), nor was there a 
difference in BAI-scores, F(1,116) = 1.75, p = .19, ηp2 = 0.01, Single episode: M = 8.19, SD = 9.97; 
Recurrent: M = 10.60, SD = 8.67. Participants were non-hospitalized, and only 7 % in the PD and 19 
% in the CD group used antidepressant medication. 
Comorbidity in the sample was limited. Anxiety diagnoses were most common, with social 
phobia or mild generalized anxiety being reported by approximately 10 participants in each of the 
depressed groups. Post-traumatic stress disorder (PTSD) was reported by only one participant. There 
were no significant differences between the depression groups on clinical variables other than BDI-II 
and BAI (see Table 1). 
Table 1. Demographic and clinical characteristics of the participants (n = 168). 
Variable Never 
depressed 
(n = 50) 
Previously 
depressed  
(n = 81) 
Currently 
depressed 
(n = 37) 
Significance tests 
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aBDI-II = Beck Depression inventory, second edition; b BAI = Beck Anxiety Inventory, cMissing: n = 1; donly 
depressed groups analysed. 
 
Looking at all groups together, there were no significant differences in demographic or clinical 
variables between participants providing or missing cortisol measures, F(1,166) = 0.12 – 1.40, p = .24 
– .73, χ2 (1) = 0.004 - .58, p = .23 -.95). Furthermore, there were no differences between the groups in 
proportion of participants missing cortisol samples, χ2 (2) = 0.80, p = .67. When looking at patterns of 
missingness in the separate groups there were no significant differences in the ND and PD groups. 
However, in the CD group participants missing one or both cortisol measures had significantly higher 
scores on the BDI-II, F(1,35) = 12.35, p = .001, ηp2 = 0.26 (M: 22.44 vs. 32.90). In addition, they 
tended to be younger, F(1,35) = 8.26, p = .007, ηp2 = 0.19 (M: 40.63 vs. 29.00), and have lower 
education, F(1,35) = 4.29 , p = .046, ηp2 = 0.11 (M: 14.52 vs. 11.70 years). 
3.2. The association between salivary cortisol and depressive symptoms 
Analyses of the full sample of participants indicated a small, but significant positive 
relationship between BDI-II scores and salivary cortisol measured in the evening, rs = 0.22, p = .007. 
The association between BDI-II scores and salivary morning cortisol was non-significant, rs = 0.01, p 
= .44.  
The correlation between depressive symptoms and cortisol was also analysed separately within 
the three groups. There were no significant relationships between BDI-II and any cortisol measure 
within any group (morning cortisol: rs = -0.04 – 0.11, p = .42 - .85; evening cortisol: rs = -0.05 – 0.22, 
Female, n (%) 39 (78.0) 71 (87.7) 27 (73.0) χ2 (2) = 4.23, p = .12 
Age, M (SD) 38.1 (12.7) 37.4 (9.6) 37.5 (12.0) F(2,165) = 0.06, p = .95 
Education, years, M (SD) 15.1 (3.6) 15.1 (2.6) 13.8 (3.8) F(2,165) = 2.53, p = .08 
BDI-II a, M (SD) 3.1 (2.9) 7.7 (6.7) 25.3 (9.2) F(2,165) = 133.42, p < .001 
BAI b,c 2.3 (2.8) 6.4 (6.3) 17.4 (9.8) F (2,164) = 58.75, p < .001 
Right handed, n (%) 45 (90.0) 75 (92.6) 35 (94.6) Fisher’s Exact Test = 0.65, p = .81 
Intellectual abilities c, M (SD)     
Comprehension 23.4 (5.7) 23.0 (4.5) 22.2 (4.6) F(2,164) = 0.68, p = .51 
Picture Completion 21.0 (2.7) 21.0 (2.9) 20.9 (3.1) F(2,164) = 0.03, p = .97 
Medication, n (%) 0  6 (7.4) 7 (18.9) Fisher’s Exact Test: p = .11 d 
Recurrent depression, n (%) 0 55 (67.9) 27 (73.0) χ2 (1) = 0.31, p = .58 d 
≥ 3 depressive episodes, n (%) 0  36 (44.4) 19 (51.4) χ2 (1) = 0.49, p = .49 d 
≥ 5 years in remission  51 (63.0)   
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p = .21 - .72). However, these analyses were restricted by limited sample size, especially in the CD (n 
= 31) and ND (n = 42) groups. 
As the groups differed significantly on anxiety symptoms measured with BAI, analyses were 
performed to investigate if anxiety mediated the association between BDI-II and evening cortisol. The 
Sobel test indicated that there was no significant mediation effect of BAI, Zs = -0.60, SE = 0.01, p = 
.55.  Therefore, BAI is not controlled for in the following analyses of group-differences.  
3.3. Group-differences in salivary cortisol  
A comparison of salivary cortisol in the three groups (CD, PD and ND) using an independent 
Samples Kruskal-Wallis Test found no significant differences between the groups on morning cortisol, 
n = 130, χ2(2) = 1.08, p = .58, rND-CD = -0.02, rND-PD = 0.09, rCD-PD = -0.08. However, for evening 
cortisol there was a significant difference between the groups, n = 123, χ2(2) = 8.59, p = .01, with a 
mean rank cortisol score of 78.00, 60.93, 51.78 for the CD, PD and ND groups, respectively. Pairwise 
comparisons indicated a significant difference after adjustment for multiple tests between the ND and 
CD group (CD > ND, p = .01, r = 0.35; rND-PD = 0.13, rCD-PD = 0.23). Furthermore, an independent-
samples Jonckheere-Terpstra test of ordered alternatives showed a statistically significant trend of 
higher median cortisol levels across groups with higher level of depression (CD >PD >ND), TJT = 
2979.50, z = 2.89, p = .004. Pairwise comparisons found that there was a significant difference 
between CD and ND (CD > ND, p = .01), and between the CD and PD groups (CD >PD, p = .04). 
Since some previously depressed participants had elevated scores on BDI-II, the analysis was re-run 
excluding 13 individuals with BDI-II scores above 13. This did not alter the results.  
Similarly, an independent Samples Kruskal-Wallis Test indicated no significant differences 
between the groups based on frequency of depression (never, single, recurrent) in morning cortisol, n 
= 130, χ2(2) = 0.58, p = .75, rND-Single = 0.10, rND-Recurrent = 0.08, rSingle-Recurrent = -0.05. The difference for 
evening cortisol was marginally significant, n = 123, χ2(2) = 6.08, p = .048, with a mean rank cortisol 
score of 69.57, 58.38, 51.78 for the groups with recurrent, single or no depression, respectively. 
Pairwise comparisons showed that the largest difference in evening cortisol was between the ND and 
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recurrent depression group, p = .02, r = 0.24. However, this difference did not reach significance after 
adjustment for multiple tests (p =.05). The other pairwise comparisons did not reach significance, ND 
= Single, p = .47, r = 0.11; Recurrent = Single, p = .18, r = 0.15. Looking at the Jonckheere-Terpstra 
test of ordered alternatives, there was a statistically significant trend for higher median levels of 
evening cortisol across the groups, TJT = 2879.50, z = 2.50, p = .01. Evening cortisol was significantly 
higher in the recurrent depression group compared to the ND group, p = 03. 
3.4. Neuropsychological profiles in current and previous depression 
To reduce the number of neuropsychological test-variables a PCA was performed. This 
analysis yielded the following 6 components: 1. Psychomotor speed, 2. Verbal memory, 3. Executive 
function, 4. Working memory, 5. Verbal fluency, and 6. Attention (see Table 2 for factor loadings for 
all the included neuropsychological variables). Index-scores were calculated using z-transformed 
variable scores.  
 
Table 2. Factor loadings for the 6 neuropsychological components. Based on the principal components analysis 
with oblimin oblique rotation.  
Variables  Components 
 
 1 2 3 4 5 6 
 
Trail Making Test A 
-.816 
     
Trail Making Test B -.663      
Colour-Word Interference Test – Inhibition -.657      
Digit Symbol Coding .645      
Color-Word Interference Test – Inhibition/Switching -.569      
Color-Word Interference Test – Colour Naming  -.456      
CVLT-IIa - Short Delay Free Recall   .961     
CVLT-IIa - Long Delay Free Recall   .935     
CVLT-IIa - Trials 1-5 Total  .879     
WCSTb - Perseverative Responses   -.869    
WCSTb - Categories Completed   -.825    
Seashore Rythm Test    .800   
Digit Span Backward    .767   
Digit Span Forward    .748   
Color-Word Interference Test – Word Reading    -.425   
Verbal Fluency – Category Switching     .880  
Verbal Fluency – Category Fluency      .771  
Verbal Fluency – Letter Fluency      .550  
CalCAPc - Sequential Reaction Time 1      -.946 
CalCAPc- Sequential Reaction Time 2      -.775 
CalCAPc - Choice Reaction Time       -.630 
   
aCVLT-II = California Verbal Learning Test, second edition, bWCST = Wisconsin Card Sorting Test, cCalCAP = 
California Computerized Assessment Package RT. 
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Results from the repeated-measures MANOVA showed different cognitive profiles between 
the three groups (CD, PD, ND) as indicated by a significant interaction between group and the within-
subjects factor cognitive component, ɅPillai = 0.15, F(10,318) = 2.48, p = .007, ηp2 = 0.03, ηG2 = 0.02 
(see Table 3 for mean index-scores for the groups and Figure 1 for plots). The interaction was 
significant irrespective of which multivariate test statistic was used. Pillai’s trace provided the most 
conservative estimate. Including medication as a covariate did not substantially alter the overall 
results, with the interaction between group and cognition being significant, ɅPillai = 0.14, F(10,316) = 
2.42, p = .009. There was no significant interaction between medication and the cognitive components.   
Separate univariate ANOVAs yielded significant differences between the groups on the 
Working memory and Attention components (see Table 3). Bonferroni corrected post hoc analyses 
showed that the ND group scored significantly higher on Working memory compared to the CD group 
(p = .04). The PD group also performed better than the CD group, but this difference did not reach 
significance (p = .06). In addition, the ND group performed significantly better than both the CD and 
PD groups on Attentional tasks (ND > CD, p = .003; ND > PD, p = .01). Re-running the analysis 
without previously depressed participants with BDI-II scores above 13 (total n = 152) confirmed the 
findings (Working memory: ND > CD, p = .04; PD > CD, p = .048; Attention: ND > CD, p = .003; 
ND > PD, p = .002). 
 
Table 3. Mean index scores for the never, previously or currently depressed groups, and results from follow-up 
ANOVAs comparing the cognitive components across groups. 
 
Component M (SD) Never depressed 
(n = 48) 
Previously depressed  
(n = 81) 
Currently depressed 
(n = 36) 
ANOVA 
F (2,162) 
Psychomotor speed .03 (.92) .05 (.72) -.09 (.62) 0.46, p = .63, ηp2 = 0.01 
Verbal memory -.10 (.94) .07 (.91)  .002 (.98) 0.47, p = .63, ηp2 = 0.01 
Executive function 
(reversed direction)  
-.17 (.78) .07 (.89) .01 (.88) 1.21, p = .30, ηp2 = 0.01 
Working memory .14 (.94) .07 (.76) -.31 (.68) 3.68, p = .03, ηp2 = 0.04 
Verbal fluency .18 (.84) -.03 (.78) -.15 (.78) 2.00, p = .14, ηp2 = 0.01 
Attention .33 (.78) -.08 (.72) -.23 (.87) 6.51, p = .002, ηp2 = 0.07 
 
 
Høifødt, R.S.            Cortisol and cognitive profile in depression                                                               17 
 
 
Figure 1: Neuropsychological profiles of cognitive index scores for the Never depressed (ND), Previously 
depressed (PD) and Currently depressed (CD) groups. 
 
3.5. Cortisol and neuropsychological functioning 
The last aim was to investigate the association between salivary cortisol and performance on 
neuropsychological measures. Results of six hierarchical regression analyses using mean index-scores 
for each of the components as dependent variables, showed no significant effects of cortisol measures 
(morning or evening samples) on neuropsychological performance when controlling for demographic 
variables (gender, age and education), medication use, depressive symptoms (BDI-II) and anxiety 
symptoms (BAI; See Supplementary Table 1 for coefficients for the cortisol measures). Including 
depression frequency (no, single or recurrent episodes) as a covariate did not alter the results of the 
regression analyses. Age and education were the two variables with the most significant impact on 
performance on the neuropsychological tests. The only clinical variable showing significant effects on 
neuropsychological performance was medication use, which had a significantly negative effect on 
Executive function (B = .88, SEB = .29, β = .25, p = .002, CI = 0.30 – 1.44). The included variables 
could explain 32.0 % (adjusted R2 = .27) of the Psychomotor speed component, 34.3 % (adjusted R2 = 
.29) of the Verbal memory component, and 24.8 % (adjusted R2 = .19) of the component Working 
memory. However, the model explained only 16.6 % (adjusted R2 = .10) of Executive function, 14.0 % 
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The main finding of the present study is that an elevation in salivary evening cortisol, but not 
morning cortisol, was significantly related to depressive symptoms in a sample including non-
hospitalized, mildly to moderately depressed individuals. There was no significant difference between 
individuals with previous depression and the never depressed controls. However, the results indicated 
that evening cortisol levels might be higher in individuals who had experienced recurrent depressive 
episodes, irrespective of current symptoms, compared to those who had never experienced depression 
or only had a single episode. There were significantly different cognitive profiles for the currently, 
previously and never depressed groups. The currently depressed group showed impaired working 
memory compared to the group with no depression, and both the currently and previously depressed 
performed poorer on attentional tasks. Despite findings indicating a relation between depression and 
cortisol levels, and depression and cognition, there was no support for relationship between morning 
or evening cortisol levels and cognitive functioning.  
4.2. Salivary cortisol and depression  
The relation between evening cortisol level and depression was supported in the group 
comparisons showing significantly elevated evening cortisol in the currently depressed group 
compared to the never depressed controls and by a small, but significant correlation between BDI-II 
scores and evening cortisol. These results are in line with several other studies and meta-analyses 
supporting hypersecretion of cortisol in depression (Knorr et al., 2010; Stetler and Miller, 2011; 
Vreeburg et al., 2009). Elevations in cortisol are found to be more pronounced in patients who are 
hospitalized or have a depression characterized by psychotic, melancholic or endogenous symptoms 
(Keller et al., 2016; Stetler and Miller, 2011). In fact, some previous studies have failed to find 
evidence for different salivary cortisol profiles when comparing outpatients with mild to moderate 
depression (Krogh et al., 2012), or patients with non-psychotic depression (Keller et al., 2016) to 
healthy controls. In contrast, the present study indicates that cortisol levels may be significantly 
elevated, at least in the evening, also in patient groups with less severe depression. This is consistent 
with a recent study including outpatients with depression of moderate severity and remitted depressed 
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patients (Salvat-Pujol et al., 2017). They found a significant difference in evening cortisol between 
depressed patients and healthy controls, but no differences between groups on other cortisol measures.  
Contrary to two previous meta-analyses (Knorr et al., 2010; Stetler and Miller, 2011), the 
present study found no significant differences in morning cortisol between depressed and non-
depressed individuals. Several studies have also found that the cortisol awakening response (CAR); 
that is, the sharp rise in cortisol secretion after waking, can be greater in depression (e.g., Vreeburg et 
al., 2009). Measuring the CAR reflects the distinct features of morning cortisol activity in a more 
exact manner. Our null-finding concerning morning cortisol, therefore, should be interpreted 
cautiously due to the use of only one measurement point and the uncertainty of the exact timing in 
relation to awakening.  
The present study also included a group of previously depressed individuals in a remitted 
state. This group had evening cortisol levels at an intermediate level compared to the currently and 
never depressed, but were not significantly different from the never depressed group. Thus, consistent 
with some previous studies (Hinkelmann et al., 2012; Reppermund et al., 2007), our results indicate 
that cortisol levels may tend to normalize with symptom remittance. However, when comparing 
groups with recurrent and single depression, irrespective of current symptoms, the results were more 
ambiguous. The group with recurrent depression had higher levels of evening cortisol compared to the 
never depressed group, although when adjusting for multiple tests, the difference was only significant 
on the Jonckheere-Terpstra test. This finding may lend preliminary support to the notion that elevated 
cortisol levels is not solely related to the depressive state, but rather may be affected by repeated 
exposure to depression, or may be a trait marker predisposing individuals for a more recurrent course 
of depression. The latter has been suggested by earlier research showing that sustained HPA-axis 
dysregulation is predictive of future relapses (Zobel et al., 2001). Furthermore, as our study only 
measured cortisol level, it cannot be ruled out that HPA-axis dysregulation measured with the CAR or 
the dexamethasone suppression/corticotropin-releasing-hormone (DEX/CRH) challenge test may 
persist despite symptom remission, as indicated by some studies (Bhagwagar et al., 2003; Vreeburg et 
al., 2009).  
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4.3. Neuropsychological functioning in current and previous depression 
The search for a neuropsychological profile characteristic for major depression has proven difficult, 
due to the heterogeneity of the disorders. The present results indicate specific impairments in the 
depressed group related to working memory and attention, with significantly poorer results on 
attentional tasks persisting in a remitted state. This result contradicts previous findings supporting 
generalized impairments across multiple neuropsychological domains both in the acute phase of 
depression (e.g., Egeland et al., 2005; Faust et al., 2017; Reppermund et al., 2008; Rock et al., 2014; 
Salvat-Pujol et al., 2017) and upon remission (Hasselbalch et al., 2013; Reppermund et al., 2008). The 
present study included outpatients with symptoms predominately in the mild to moderate range. More 
severe depression (e.g. psychotic depression) has been related to more substantial cognitive 
impairments both in the acute and remitted state (Gomez et al., 2006; Hasselbalch et al., 2013; Keller 
et al., 2016; McDermott and Ebmeier, 2009). In fact, a previous study of outpatients with mild to 
moderate depression failed to find any differences on memory-related tasks (Krogh et al., 2012). Thus, 
the inclusion of a sample of milder severity in the present study, may possibly explain the absence of 
more widespread impairments.  
The finding of significantly poorer performance in the previously depressed compared to the 
never depressed group on attentional tasks, but not on the working memory component may be a bit 
surprising at first glance. However, the working memory component included only one task (out of 
four) requiring participants to manipulate information, as opposed to tasks requiring maintenance of 
information in memory. A meta-analysis found that the effect size for the difference between 
depressed and healthy individuals was small for maintenance working memory and significantly larger 
for manipulation tasks (Snyder, 2013). Therefore, the working memory component of this study had 
relatively low complexity. In addition, the tasks loading on the attention component were challenging, 
as they relied on speed of information processing and required participants to sustain attention for 
approximately 10 minutes.    
Consistent with the present results, it has been suggested that attentional deficits may play an 
important role in cognitive dysfunction in depression, as performance in all cognitive domains 
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depends on the ability to maintain a certain level of attention (Reppermund et al., 2008). In addition, 
attention has been proposed as a possible trait marker in depression (Douglas and Porter, 2009; 
Hasselbalch et al., 2011). Our results support that this conclusion may hold also for patient groups 
with less severe depression.   
4.4. Cortisol and neuropsychological functioning 
The role of cortisol as a possible mechanism for cognitive impairment in depression has so far 
been an unresolved issue. Findings have been mixed, both for studies looking at the association 
between cognitive performance and cortisol levels (e.g., Egeland et al., 2005; Gomez et al., 2006; 
Keller et al., 2016; Krogh et al., 2012; Michopoulos et al., 2008; Vythilingam et al., 2004), and HPA-
axis reactivity measured with the DEX(/CRH) challenge test (Reppermund et al., 2007). In the present 
study hierarchical regression analyses using cognitive indexes as dependent variables, did not support 
a significant association between morning or evening cortisol levels and neuropsychological 
performance, when important covariates such as age and education were controlled for. Again, it is 
possible that the relationship between cortisol and cognition is stronger for patient groups with more 
severe types of depression, in which HPA-axis disturbances may be more pronounced than in the 
present sample. This would be consistent with some studies comparing psychotic and non-psychotic 
depressed patients (Gomez et al., 2006; Keller et al., 2016). However, in a recent study including 
moderately depressed patients and remitted patients, a blunted CAR was associated with poorer 
performance in the patient groups on some cognitive tasks, and the diurnal cortisol slope also showed 
relations to cognitive performance, although the direction of this association differed between remitted 
and non-remitted patients (Salvat-Pujol et al., 2017).  
The null-finding of the present study must be interpreted with some caution due to 
methodological issues. Cortisol was measured at only two time-points. In addition, the 
neuropsychological testing was not performed at the same specific time of day for all participants, 
which would have been preferable considering the circadian rhythm of cortisol. Further, due to the 
limited sample size, it cannot be ruled out that there are small effects that the analyses were not 
powered to detect.  Nevertheless, peripheral cortisol measures alone may not adequately tap into the 
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complexity of mechanisms relating the glucocorticoid system and cognition, and looking at the 
relation to other steroid hormones and genetic factors may provide a fuller picture. 
4.5. Limitations  
The present study has some limitations. The cross-sectional design of the study precludes 
interpretation of how cortisol levels or cognitive functioning develops during the course of the 
disorder, as well as the development of the disorder over time with regard to severity and chronicity. 
Further, cortisol was measured only once in the morning and once in the evening. More measurement 
points over more than one day would have increased the reliability. In addition, ambulatory salivary 
cortisol measurements impose challenges related to compliance with sampling instructions. In this 
study, the timing of measurement varied, and the relation to time of waking was uncertain. This 
especially challenges the reliability of the morning measure, considering the characteristics of the 
CAR. However, time of measurement was not significantly correlated with neither cortisol level nor 
neuropsychological functioning, and was therefore not controlled for in the analyses. Another 
limitation is that exclusion criteria did not include somatic disorders that may influence HPA-axis 
functioning or the use of corticosteroid treatment. Furthermore, cortisol levels may be influenced by a 
number of confounding factors (Hellhammer et al., 2009), including cycle phase, oral contraceptives 
and menopause, tobacco consumption, body mass index, intense exercise and stress. These variables 
were not assessed, and thus, cannot be controlled for. Another issue is the severity of past depressive 
episodes in the PD-group which was not thoroughly assessed. However, participants were all 
outpatients, and 77 % (n = 62) of the PD-group were recruited from a previous study among mildly to 
moderately depressed outpatient younger adults (Wang et al., 2006). Based on this and the fact that so 
few participants used antidepressant medications, we consider it reasonable to characterize the 
previously depressed sample as mildly to moderately previously depressed. Although the proportion of 
currently or previously depressed participants using psychotropic medications was small, medication 
use did affect neurpsychological performance. Lack of information about medication type and doses 
limited further explortation of this relationship. Further, the present study did not control for childhood 
traumas, which may be related to cortisol hypersecretion irrespective of depressive symptoms (Lu et 
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al., 2016). Furthermore, PTSD can be related to reduced cortisol concentrations (Wingenfeld and 
Wolf, 2011). The uncertain interrater reliability of comorbid diagnoses is a limitation. However, it 
provides an estimate, indicating that comorbidity in the present study was limited and mainly included 
social and generalized anxiety disorders, and not PTSD. In addition, anxiety symptoms (BAI) did not 
mediate the association between BDI-II and cortisol. Thus, it is unlikely that comorbidity had a large 
effect on the results. Finally, the analysis of patterns of missingness indicated that participants lacking 
cortisol measures had more severe depression symptoms compared to those completing the cortisol 
measurements. Due to these non-random missing data, the results should be interpreted with caution. 
In addition, the study was not powered to detect small effects, and missing cortisol data reduced the 
sample size, and thus the achieved power for group-comparisons for cortisol was less than adequate. 
This increases the probability of a type-II error. However, the effect sizes gives an indication of the 
size of the effects and indicates that non-significant effects were generally small (r < 0.2).   
4.6. Conclusion 
The present study indicates that also patient groups with depression of mild to moderate 
severity may have significantly elevated evening cortisol levels. In addition, their cognitive profile is 
significantly different from that of never depressed individuals, but only with specific mild 
impairments on working memory and attentional tasks. Impairments in attention were also evident in a 
group of previously depressed individuals, indicating that this could be a trait-marker in depression. 
Despite the relation between depression and cortisol and depression and specific cognitive 
impairments, the present study did not find a significant association between morning or evening 
cortisol levels and cognitive performance.  
 
Funding: This study was supported by ‘‘The National Program for Integrated Clinical Specialist and 
PhD-training for Psychologists’’ in Norway. This program is a joint cooperation between the 
Universities of Bergen, Oslo, Tromsø, the Norwegian University of Science and Technology 
(Trondheim), the Regional Health Authorities, and the Norwegian Psychological Association. The 
Høifødt, R.S.            Cortisol and cognitive profile in depression                                                               24 
 
program is funded jointly by The Ministry of Education and Research and The Ministry of Health and 
Care Services. The study was also supported in part by the Psychiatric Research Centre of Northern 
Norway. The funding source had no involvement in study design, data 
collection/analysis/interpretation or in writing the report. 
Acknowledgement: We would like to thank Professor Kjetil Sundet for invaluable advice on 
statistical methods, neuropsychological profiling and structuring and editing of the paper, and 
Associate Professor Gerit Pfuhl for statistical advice in the process of revision. Thanks also to the 
participants and the research assistants who contributed to the data collection. 
Contributors: Study concept and design: MH, CEAW, KW, YF and ME. Data acquisition and/or 
analysis: RSH, MH and YF. Drafting the manuscript: RSH. Critical revision of the manuscript for 
important intellectual content: RSH, MH, CEAW, KW, YF and ME. Approval of the submitted 
version: RSH, MH, CEAW, KW, YF and ME. 
Declaration of interest: None.  
References 
American Psychiatric Association, 2000. Diagnostic and Statistical Manual of Mental Disorders, 4th 
ed. American Psychiatric Association, Washington. 
Anacker, C., Zunszain, P.A., Carvalho, L.A., Pariante, C.M., 2011. The glucocorticoid receptor: Pivot 
of depression and of antidepressant treatment? Psychoneuroendocrinology 36, 415-425. 
Beck, A.T., Steer, R.A., 1993. Beck Anxiety Inventory: Manual. The Psychological Corporation, San 
Antonio, TX. 
Beck, A.T., Steer, R.A., Brown, G.K., 1996. BDI-II, Beck Depression Inventory: Manual. The 
Psychological Corporation, San Antonio, TX. 
Bhagwagar, Z., Hafizi, S., Cowen, P.J., 2003. Increase in concentration of waking salivary cortisol in 
recovered patients with depression. Am J Psychiatry 160, 1890-1891. 
Biringer, E., Lundervold, A., Stordal, K., Mykletun, A., Egeland, J., Bottlender, R., Lund, A., 2005. 
Executive function improvement upon remission of recurrent unipolar depression. Eur Arch 
Psychiatry Clin Neurosci 255, 373-380. 
Brown, E.S., J. Woolston, D., Frol, A., Bobadilla, L., Khan, D.A., Hanczyc, M., Rush, A.J., 
Fleckenstein, J., Babcock, E., Cullum, C.M., 2004. Hippocampal volume, spectroscopy, 
cognition, and mood in patients receiving corticosteroid therapy. Biol Psychiatry 55, 538-545. 
Colla, M., Kronenberg, G., Deuschle, M., Meichel, K., Hagen, T., Bohrer, M., Heuser, I., 2007. 
Hippocampal volume reduction and HPA-system activity in major depression. J Psychiatr Res 
41, 553-560. 
Delis, D.C., Kaplan, E., Kramer, J.H., 2001. D-KEFS: Executive function system : Examiner's manual 
Psychological Corporation, San Antonio, TX. 
Delis, D.C., Kramer, J.H., Kaplan, E., Ober, B.A., 2004. California Verbal Learning Test – Second 
Edition (CVLT-II). Norwegian manual supplement. Pearson Assessment, Stockholm, Sweden. 
Douglas, K.M., Porter, R.J., 2009. Longitudinal assessment of neuropsychological function in major 
depression. Aust N Z J Psychiatry 43, 1105-1117. 
Høifødt, R.S.            Cortisol and cognitive profile in depression                                                               25 
 
Egeland, J., Lund, A., Landrø, N.I., Rund, B.R., Sundet, K., Asbjørnsen, A., Mjellem, N., Roness, A., 
Stordal, K.I., 2005. Cortisol level predicts executive and memory function in depression, 
symptom level predicts psychomotor speed. Acta Psychiatr Scand 112, 434-441. 
Faul, F., Erdfelder, E., Lang, A.-G., Buchner, A., 2007. G*Power 3: A flexible statistical power 
Analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39, 
175-191. 
Faust, K., Nelson, B.D., Sarapas, C., Pliskin, N.H., 2017. Depression and performance on the 
Repeatable Battery for the Assessment of Neuropsychological Status. Appl Neuropsychol 
Adult 24, 350-356. 
First, M.B., Spitzer, R.L., Gibbon, M., Williams, J.B., 1997. User's guide for the Structured clinical 
interview for DSM-IV axis I disorders SCID-I: Clinician version. American Psychiatric Press, 
Washington, DC. 
Forget, H., Lacroix, A., Cohen, H., 2002. Persistent cognitive impairment following surgical treatment 
of Cushing's syndrome. Psychoneuroendocrinology 27, 367-383. 
Fydrich, T., Dowdall, D., Chambless, D.L., 1992. Reliability and validity of the Beck Anxiety 
Inventory. J Anxiety Disord 6, 55-61. 
Gomez, R.G., Fleming, S.H., Keller, J., Flores, B., Kenna, H., DeBattista, C., Solvason, B., 
Schatzberg, A.F., 2006. The neuropsychological profile of psychotic major depression and its 
relation to cortisol. Biol Psychiatry 60, 472-478. 
Halvorsen, M., Høifødt, R.S., Myrbakk, I.N., Wang, C.E.A., Sundet, K., Eisemann, M., Waterloo, K., 
2012. Cognitive function in unipolar major depression: A comparison of currently depressed, 
previously depressed, and never depressed individuals. J Clin Exp Neuropsychol 34, 782-790. 
Halvorsen, M., Waterloo, K., Sundet, K., Eisemann, M., Wang, C.E.A., 2011. Verbal learning and 
memory in depression: A 9-year follow-up study. Psychiatry Res 188, 350-354. 
Hammar, Å., Årdal, G., 2009. Cognitive functioning in major depression—A summary. Front Hum 
Neurosci 3. 
Hasselbalch, B.J., Knorr, U., Hasselbalch, S.G., Gade, A., Kessing, L.V., 2013. The cumulative load 
of depressive illness is associated with cognitive function in the remitted state of unipolar 
depressive disorder. Eur Psychiatry 28, 349-355. 
Hasselbalch, B.J., Knorr, U., Kessing, L.V., 2011. Cognitive impairment in the remitted state of 
unipolar depressive disorder: A systematic review. J Affect Disord 134, 20-31. 
Heaton, R.K., 1993. WCST-64TM: Computer version 2: Research edition: User's manual. 
Psycological Assessment Resources, Odessa, FL. 
Hellhammer, D.H., Wüst, S., Kudielka, B.M., 2009. Salivary cortisol as a biomarker in stress research. 
Psychoneuroendocrinology 34, 163-171. 
Hinkelmann, K., Moritz, S., Botzenhardt, J., Muhtz, C., Wiedemann, K., Kellner, M., Otte, C., 2012. 
Changes in cortisol secretion during antidepressive treatment and cognitive improvement in 
patients with major depression: A longitudinal study. Psychoneuroendocrinology 37, 685-692. 
Hinkelmann, K., Muhtz, C., Dettenborn, L., Agorastos, A., Moritz, S., Wingenfeld, K., Spitzer, C., 
Gold, S.M., Wiedemann, K., Otte, C., 2013. Association between cortisol awakening response 
and memory function in major depression. Psychol Med 43, 2255-2263. 
Holsboer, F., 2000. The Corticosteroid Receptor Hypothesis of Depression. Neuropsychopharmacol 
23, 477-501. 
IBM Corp., Released 2016. IBM SPSS Statistics for Windows, Version 24.0. ed. IBM Corp, Armonk, 
NY. 
Jin, R.O., Mason, S., Mellon, S.H., Epel, E.S., Reus, V.I., Mahan, L., Rosser, R.L., Hough, C.M., 
Burke, H.M., Mueller, S.G., Wolkowitz, O.M., 2016. Cortisol/DHEA ratio and hippocampal 
volume: A pilot study in major depression and healthy controls. Psychoneuroendocrinology 
72, 139-146. 
Juruena, M.F., Cleare, A.J., Pariante, C.M., 2004. The hypothalamic pituitary adrenal axis, 
glucocorticoid receptor function and relevance to depression. Rev Bras Psiquiatr 26, 189-201. 
Kaymak, S.U., Demir, B., Şentürk, S., Tatar, I., Aldur, M.M., Uluǧ, B., 2010. Hippocampus, 
glucocorticoids and neurocognitive functions in patients with first-episode major depressive 
disorders. Eur Arch Psychiatry Clin Neurosci 260, 217-223. 
Keller, J., Gomez, R., Williams, G., Lembke, A., Lazzeroni, L., Murphy Jr, G.M., Schatzberg, A.F., 
Høifødt, R.S.            Cortisol and cognitive profile in depression                                                               26 
 
2016. HPA axis in major depression: Cortisol, clinical symptomatology and genetic variation 
predict cognition. Mol Psychiatry 22, 527. 
Kjærgaard, M., Arfwedson Wang, C.E., Waterloo, K., Jorde, R., 2014. A study of the psychometric 
properties of the Beck Depression Inventory-II, the Montgomery and Åsberg Depression 
Rating Scale, and the Hospital Anxiety and Depression Scale in a sample from a healthy 
population. Scand J Psychol 55, 83-89. 
Knorr, U., Vinberg, M., Kessing, L.V., Wetterslev, J., 2010. Salivary cortisol in depressed patients 
versus control persons: A systematic review and meta-analysis. Psychoneuroendocrinology 
35, 1275-1286. 
Krogh, J., Videbech, P., Renvillard, S.G., Garde, A.H., Jørgensen, M.B., Nordentoft, M., 2012. 
Cognition and HPA axis reactivity in mildly to moderately depressed outpatients: A case 
control study. Nord J Psychiatry 66, 414-421. 
Lakens, D., 2013. Calculating and reporting effect sizes to facilitate cumulative science: A practical 
primer for t-tests and ANOVAs. Frontiers in Psychology 4. 
Lu, S., Gao, W., Huang, M., Li, L., Xu, Y., 2016. In search of the HPA axis activity in unipolar 
depression patients with childhood trauma: Combined cortisol awakening response and 
dexamethasone suppression test. J Psychiatr Res 78, 24-30. 
Lupien, S.J., Maheu, F., Tu, M., Fiocco, A., Schramek, T.E., 2007. The effects of stress and stress 
hormones on human cognition: Implications for the field of brain and cognition. Brain Cognit 
65, 209-237. 
Mannie, Z.N., Harmer, C.J., Cowen, P.J., 2007. Increased waking salivary cortisol levels in young 
people at familial risk of depression. Am J Psychiatry 164, 617-621. 
McDermott, L.M., Ebmeier, K.P., 2009. A meta-analysis of depression severity and cognitive 
function. J Affect Disord 119, 1-8. 
McKay, M.S., Zakzanis, K.K., 2010. The impact of treatment on HPA axis activity in unipolar major 
depression. J Psychiatr Res 44, 183-192. 
Michopoulos, I., Zervas, I.M., Pantelis, C., Tsaltas, E., Papakosta, V.M., Boufidou, F., Nikolaou, C., 
Papageorgiou, C., Soldatos, C.R., Lykouras, L., 2008. Neuropsychological and hypothalamic 
pituitary-axis function in female patients with melancholic and non-melancholic depression. 
Eur Arch Psychiatry Clin Neurosci 258, 217-225. 
Miller, E.N., 1993. CalCAP: California Computerized Assessment Package manual. Norland 
Software, Los Angeles, CA. 
Reitan, R.M., Wolfson, D., 1993. The Halstead-Reitan Neuropsychological Test Battery: Theory and 
clinical interpretation, 2nd ed. Neuropsychology Press, Tucson, AZ. 
Reppermund, S., Ising, M., Lucae, S., Zihl, J., 2008. Cognitive impairment in unipolar depression is 
persistent and non-specific: Further evidence for the final common pathway disorder 
hypothesis. Psychol Med 39, 603-614. 
Reppermund, S., Zihl, J., Lucae, S., Horstmann, S., Kloiber, S., Holsboer, F., Ising, M., 2007. 
Persistent cognitive impairment in depression: The role of psychopathology and altered 
hypothalamic-pituitary-adrenocortical (HPA) system regulation. Biol Psychiatry 62, 400-406. 
Rock, P.L., Roiser, J.P., Riedel, W.J., Blackwell, A.D., 2014. Cognitive impairment in depression: A 
systematic review and meta-analysis. Psychol Med 44, 2029-2040. 
Salvat-Pujol, N., Labad, J., Urretavizcaya, M., de Arriba-Arnau, A., Segalàs, C., Real, E., Ferrer, A., 
Crespo, J.M., Jiménez-Murcia, S., Soriano-Mas, C., Menchón, J.M., Soria, V., 2017. 
Hypothalamic-pituitary-adrenal axis activity and cognition in major depression: The role of 
remission status. Psychoneuroendocrinology 76, 38-48. 
Snyder, H.R., 2013. Major depressive disorder is associated with broad impairments on 
neuropsychological measures of executive function: A meta-analysis and review. Psychol Bull 
139, 81-132. 
Steer, R.A., Ranieri, W.F., Beck, A.T., Clark, D.A., 1993. Further evidence for the validity of the 
Beck Anxiety Inventory with psychiatric outpatients. J Anxiety Disord 7, 195-205. 
Stetler, C., Miller, G.E., 2011. Depression and hypothalamic-pituitary-adrenal activation: A 
quantitative summary of four decades of research. Psychosom Med 73, 114-126. 
Tennant, C., 2002. Life events, stress and depression: A review of recent findings. Aust N Z J  
36, 173-182. 
Høifødt, R.S.            Cortisol and cognitive profile in depression                                                               27 
 
Vreeburg, S.A., Hoogendijk, W.G., van Pelt, J., et al., 2009. Major depressive disorder and 
hypothalamic-pituitary-adrenal axis activity: Results from a large cohort study. Arch Gen 
Psychiatry 66, 617-626. 
Vythilingam, M., Vermetten, E., Anderson, G.M., Luckenbaugh, D., Anderson, E.R., Snow, J., Staib, 
L.H., Charney, D.S., Bremner, J.D., 2004. Hippocampal volume, memory, and cortisol status 
in major depressive disorder: effects of treatment. Biol Psychiatry 56, 101-112. 
Wang, C.E., Brennen, T., Holte, A., 2005. Mechanisms of recurrent depression: A cognitive battle 
model and some preliminary results. Clin Psychol Psychother 12, 427-442. 
Wang, C.E., Halvorsen, M., Sundet, K., Steffensen, A.L., Holte, A., Waterloo, K., 2006. Verbal 
memory performance of mildly to moderately depressed outpatient younger adults. J Affect 
Disord 92, 283-286. 
Wechsler, D., 2003. Wechsler Adult Intelligence Scale - 3rd ed. (WAIS-III). Norwegian manual. 
Pearson Assessment, Stockholm, Sweden. 
Wingenfeld, K., Wolf, O.T., 2011. HPA axis alterations in mental disorders: Impact on memory and 
Its relevance for therapeutic interventions. CNS Neurosci Ther 17, 714-722. 
Wittchen, H.U., Jacobi, F., 2005. Size and burden of mental disorders in Europe: A critical review and 
appraisal of 27 studies. Eur Neuropsychopharmacol 15, 357-376. 
Zobel, A.W., Nickel, T., Sonntag, A., Uhr, M., Holsboer, F., Ising, M., 2001. Cortisol response in the
 combined dexamethasone/CRH test as predictor of relapse in patients with remitted
 depression: A prospective study. J Psychiatr Res 35, 83-94. 
 
 
